FOX vs PACB · P/E 13, rev $16.30B vs rev $38.4M
Fox Corp Class B (FOX) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. PACB currently screens at market cap $387.1M.
Not investment advice. Open the FOX and PACB stock pages for the full models.
Not investment advice.